{"address1": "Portway Building", "address2": "Blocks A & B Granta Park Great Abington", "city": "Cambridge", "zip": "CB21 6GS", "country": "United Kingdom", "phone": "44 1223 261 503", "website": "https://www.bicycletherapeutics.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. It is developing BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease; BT5528, a BTC that is in a Phase I/II clinical trial targeting Ephrin type-A receptor 2; and BT8009, which is in Phase I/II clinical trial targeting Nectin-4. The company also develops THR-149, a plasma kallikrein inhibitor for the treatment of diabetic macular edema; BT7480, a Bicycle tumor-targeted immune cell agonist (TICA) targeting Nectin-4 and agonizing; BT7455, an EphA2/CD137 Bicycle TICA; and BT7401, a multivalent CD137 agonist. In addition, it collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas, such as anti-infective, cardiovascular, dementia, central nervous system, neuromuscular, and respiratory indications. The company has a clinical trial and license agreement with the Cancer Research Technology Limited and Cancer Research UK; research collaboration agreements with AstraZeneca AB, Sanofi, Oxurion NV, and the Dementia Discovery Fund, as well as with Ionis Pharmaceuticals, Inc.; and a discovery collaboration and license agreement with Genentech Inc. for the discovery and development of Bicycle peptides for multiple immuno-oncology targets. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.", "fullTimeEmployees": 236, "companyOfficers": [{"maxAge": 1, "name": "Dr. Kevin  Lee M.B.A., Ph.D.", "age": 53, "title": "CEO & Exec. Director", "yearBorn": 1969, "fiscalYear": 2021, "totalPay": {"raw": 1403402, "fmt": "1.4M", "longFmt": "1,403,402"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Lee H. Kalowski M.B.A., MBA", "age": 41, "title": "Pres & CFO", "yearBorn": 1981, "fiscalYear": 2021, "totalPay": {"raw": 832355, "fmt": "832.36k", "longFmt": "832,355"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Sir Gregory Paul Winter CBE, FMedsci, FRS, HonFRCP, HonFTSE", "age": 71, "title": "Co-Founder, Non-Exec. Director & Member of Scientific Advisory Board", "yearBorn": 1951, "fiscalYear": 2021, "totalPay": {"raw": 40000, "fmt": "40k", "longFmt": "40,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michael  Skynner B.sc. Ph.d., Ph.D.", "age": 52, "title": "Chief Technology Officer", "yearBorn": 1970, "fiscalYear": 2021, "totalPay": {"raw": 925296, "fmt": "925.3k", "longFmt": "925,296"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Christian  Heinis", "title": "Scientific Founder", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alistair  Milnes", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Nicholas  Keen Ph.D.", "age": 54, "title": "Chief Scientific Officer", "yearBorn": 1968, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. David E. Borah CFA", "title": "VP of Capital Markets & Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Zafar  Qadir", "title": "Gen. Counsel", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Gillian  Langford", "title": "Head of Clinical and Project Management", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800}